Xilio Therapeutics, Inc. - Common Stock (NQ:XLO)
7.600
+0.170
(+2.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 30,147 |
| Open | 7.380 |
| Bid (Size) | 7.250 (100) |
| Ask (Size) | 7.830 (700) |
| Prev. Close | 7.430 |
| Today's Range | 7.380 - 7.897 |
| 52wk Range | 0.4618 - 8.090 |
| Shares Outstanding | 51,827,910 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Xilio Therapeutics Announces Pricing of Underwritten Offering
February 11, 2026
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 10, 2025
Xilio Revenue Jumps 246 Percent in Q2 ↗
August 14, 2025
Frequently Asked Questions
Is Xilio Therapeutics, Inc. - Common Stock publicly traded?
Yes, Xilio Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Xilio Therapeutics, Inc. - Common Stock trade on?
Xilio Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xilio Therapeutics, Inc. - Common Stock?
The ticker symbol for Xilio Therapeutics, Inc. - Common Stock is XLO on the Nasdaq Stock Market
What is the current price of Xilio Therapeutics, Inc. - Common Stock?
The current price of Xilio Therapeutics, Inc. - Common Stock is 7.600
When was Xilio Therapeutics, Inc. - Common Stock last traded?
The last trade of Xilio Therapeutics, Inc. - Common Stock was at 03/18/26 04:00 PM ET
What is the market capitalization of Xilio Therapeutics, Inc. - Common Stock?
The market capitalization of Xilio Therapeutics, Inc. - Common Stock is 393.89M
How many shares of Xilio Therapeutics, Inc. - Common Stock are outstanding?
Xilio Therapeutics, Inc. - Common Stock has 394M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.